Sulfadiazine Sodium

Sulfadiazine Sodium

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Sulfadiazine Sodium
Category Antibiotics
Catalog number BBF-03899
CAS 547-32-0
Molecular Weight 272.26
Molecular Formula C10H9N4NaO2S
Purity >95%

Online Inquiry

Description

Sulfadiazine sodium is a bacteriostatic sulfonamide antibiotic. It is used to treat systemic infections caused by sensitive bacteria in domestic animals, such as respiratory and urinary tract infections and mastitis, uterine sarcoiditis, peritonitis, etc. It is also effective for swine toxoplasmosis.

Specification

Synonyms (n(sup1)-2-pyrimidinylsulfanilamido)-sodium; 2-sulfanilamidopyrimidine sodium salt; 4-amino-n-2-pyrimidinyl-benzenesulfonamidmono sodium salt; monosodium 2-sulfanilamidopyrimidine; n(sup1)-2-pyrimidinylsulfanilamide monosodium salt
Storage Store at -20°C
IUPAC Name sodium;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide
Canonical SMILES C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Na+]
InChI InChI=1S/C10H9N4O2S.Na/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1
InChI Key JLDCNMJPBBKAHH-UHFFFAOYSA-N
Source Synthetic

Properties

Appearance White to Off-white Solid
Boiling Point 512.6°C at 760 mmHg
Density 1.496 g/cm3
Solubility Soluble in DMSO

Reference Reading

1. Green electrochemical synthesis of silver sulfadiazine microcrystals
Faezeh Zivari Moshfegh, Mahmood Masoudi Khoram, Davood Nematollahi RSC Adv . 2019 Aug 5;9(42):24105-24109. doi: 10.1039/c9ra04504j.
Electrochemical synthesis of silver sulfadiazine (AgSD) microcrystals was carried out galvanostatically in a special two-electrode cell equipped with a sacrificial silver rod anode and a stainless steel plate cathode. The cell used in this work consists of a small cylindrical chamber containing aqueous sulfadiazine/sodium nitrate as the anode compartment inside a larger cylindrical chamber containing nitric acid solution as the cathode compartment. The ionic connection of two chambers is carried out through a solvent surface layer. In this study, the effect of the experimental parameters such as applied current density and sodium nitrate concentration as well as nitric acid concentration on the yield and energy consumption of AgSD is discussed. The proposed method is fast and green and has unique features including synthesis in a single step, and no need for a metal salt.
2. Extravasation of Noncytotoxic Drugs: A Review of the Literature
Samit Patel, Ann Le Ann Pharmacother . 2014 Jul;48(7):870-886. doi: 10.1177/1060028014527820.
Objective:Extravasation is a potential complication associated with intravenous therapy administration. Inadvertent leakage of medications with vesicant properties can cause severe tissue necrosis, which can lead to devastating long-term consequences. Recognizing potential agents is an essential step in mitigating the risk of extravasation.Data source:A literature search was carried out using PubMed with the following key words: extravasation, soft tissue injury, phlebitis, and infiltration, from January 1961 through January 2014.Study selection and data extraction:The publications were screened manually and reviewed to identify reports for medications that included synonyms of the International Nonproprietary Name, while excluding antineoplastic agents, radiographic contrast material, investigational or nonmarketed drugs, and animal data, to yield 70 articles. Furthermore, reference citations from publications were also reviewed for relevance and yielded 4 articles.Data synthesis:We discovered 232 cases of extravasation involving 37 agents (in order of frequency): phenytoin, parenteral nutrition, calcium gluconate, potassium chloride, calcium chloride, dopamine, dextrose solutions, epinephrine, sodium bicarbonate, nafcillin, propofol, norepinephrine, mannitol, arginine, promethazine, vancomycin, tetracycline, dobutamine, vasopressin, sodium thiopental, acyclovir, amphotericin, ampicillin, cloxacillin, gentamicin, metronidazole, oxacillin, penicillin, amiodarone, albumin, furosemide, lipids, lorazepam, immunoglobulin, morphine, and sodium valproate. Potential properties contributing to extravasation include the following: pH, osmolarity, diluent, vasoactive properties, and inactive ingredients. Antidotes and supportive care agents used in the management of these cases of extravasation include hyaluronidase, phentolamine, terbutaline, topical anesthetics (such as lidocaine and prilocaine cream), topical antimicrobials (such as silver sulfadiazine and chlorhexidine), topical debridement agents (collagenase ointment), topical steroids, and topical vasodilators (nitroglycerin).Conclusion:Data on the management of noncytotoxic extravasations is sparse, consisting primarily of case reports and anecdotal evidence. Fortunately, this adverse outcome is preventable and identification of vesicant agents plays a pivotal role. The intent of this review is to provide a reference identifying noncytotoxic vesicants and the management of extravasations associated with specific agents.
3. Exploration of synthesizing fluorescent silicon nanoparticles and label-free detection of sulfadiazine sodium
Qian Su, Feng Feng, Yunfeng Bai, Jimei Xiao, Xiaoming Yang Talanta . 2020 Dec 1;220:121410. doi: 10.1016/j.talanta.2020.121410.
Herein, silica nanoparticles (SiNPs) with blue-fluorescence have been originally synthesized through one facile hydrothermal way, and this kind of SiNPs were water-soluble with the relative quantum yield of around 6%. Meanwhile, N-(triethoxysilylpropyl) urea severed as the silica source, while potassium hydrogen phthalate as the doping reagent. Also, SiNPs exhibited the acceptable stability and excitation-dependent fluorescence property. Moreover, their surfaces of the obtained SiNPs were equipped with multiple functional groups including -Si-O-Si-, -Si-H, -COOH, -NH2and -OH. Importantly, the fluorescence of SiNPs could be specifically quenched by sulfadiazine sodium (SD-Na), thus achieving a label-free detection of SD-Na, which displayed a wide linear response in the range of 0.8 μM-800 μM with a detection limit of 1.02 μM. Additionally, we explored the mechanism of SiNPs sensing SD-Na on the basis of aggregation-induced quenching. To be specific, the particle size of SiNPs increased from 29.9 nm to 203.7 nm induced by the electrostatic interactions between SiNPs and SD-Na, which was further confirmed by high resolution transmission electron microscopy. Consequently, the proposed strategy here broadened the ways of assaying sulfadiazine sodium.

Recommended Products

BBF-01825 Loganin Inquiry
BBF-02614 Nystatin Inquiry
BBF-01826 Deoxymannojirimycin Inquiry
BBF-03753 Baicalin Inquiry
BBF-05862 Epirubicin Inquiry
BBF-03754 Castanospermine Inquiry

Bio Calculators

Stock concentration: *
Desired final volume: *
Desired concentration: *

L

* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2

* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O c22h30n40
g/mol
g

Recently viewed products

Online Inquiry

Verification code
cartIcon
Inquiry Basket